Question 4048 — human blood and organs

Summary

Mr. Frank Giletti questions the Minister of Labor, Health, Solidarity and Families on the “plasma 2026” plan proposed by the French Blood Establishment (EFS). Each year, the EFS ensures plasma samples (900,000 liters) necessary for the French Laboratory of Fractionation and Biotechnologies (LFB) to manufacture medicines derived from blood. However, these levies only cover 35% of needs. national immunoglobulins. These samples are carried out in accordance with an ethical model based on volunteerism, anonymity, non-commodification of the human body and on the safety of donors by limiting plasma samples to a maximum of 24 times per year. In contrast, it is important to emphasize that the rest of the immunoglobulins are manufactured from plasma that comes from paid donations in the United States of America, where these withdrawals can reach up to 104 times per year. In order to respond to an issue of national sovereignty in the field of medicines derived from blood, the French Blood Establishment (EFS) is proposing a plasma plan with the aim of responding, over the coming years, to a constantly increasing demand for plasma throughout the world and reaching the 1,400,000 liters necessary for the LFB. So, he asks him how the Government plans to finance the French Blood Establishment (EFS) for this plasma plan which requires significant real estate, material and human resources and the mobilization of EFS teams to recruit and retain new donors.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.